Acuitas Therapeutics
Canada
1 December 2019 - 30 November 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Acuitas Therapeutics published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 5 | 0.72 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 4 | 0.59 | |
| Chemistry | 1 | 0.13 | |
Top articles by Altmetric score in current window
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
Nature Communications
2020-07-09
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
Science Translational Medicine
2020-01-08
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier
Proceedings of the National Academy of Sciences of the United States of America
2020-01-31
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 0% Domestic
- 100% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (0 total)
- Acuitas Therapeutics, Canada
- Domestic institution
Top 10 international collaborators by Share (24 total)
- Acuitas Therapeutics, Canada
- Foreign institution
-
University of Pennsylvania (Penn), United States of America (USA)
(0)
-
Imperial College London (ICL), United Kingdom (UK)
(0)
-
Penn Medicine, United States of America (USA)
(0)
-
Brown University, United States of America (USA)
(0)
-
Temple University, United States of America (USA)
(0)
-
Bioqual, Inc., United States of America (USA)
(0)
-
Duke University, United States of America (USA)
(0)
-
Center for Targeted Therapeutics and Translational Nanomedicine (CT³N), Penn, United States of America (USA)
(0)
-
National Institutes of Health (NIH), United States of America (USA)
(0)
-
The Wistar Institute, United States of America (USA)
(0)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
